Sureda, Anna
Chabannon, Christian http://orcid.org/0000-0002-3755-4889
Masszi, Tamás
Pohlreich, David
Scheid, Christof
Thieblemont, Catherine
Wahlin, Björn E.
Sakellari, Ioanna http://orcid.org/0000-0002-8883-8208
Russell, Nigel
Janikova, Andrea
Dabrowska-Iwanicka, Anna
Touzeau, Cyrille
Esquirol, Albert
Jantunen, Esa
van der Werf, Steffie
Bosman, Paul
Boumendil, Ariane
Liu, Qianying
Celanovic, Marina
Montoto, Silvia
Dreger, Peter
Funding for this research was provided by:
Sanofi
Article History
Received: 14 February 2019
Revised: 3 July 2019
Accepted: 20 July 2019
First Online: 30 September 2019
Compliance with ethical standards
:
: AS has received personal fees from Sanofi, grants and personal fees from BMS and Celgene, personal fees from Janssen, Gilead, Novartis, and Takeda. CC reports receiving fees for data transfer from EBMT during the conduct of the study and grants, and personal fees and nonfinancial support from Sanofi outside the scope of the submitted work. TM received financial supports for advisory board membership for AbbVie, BMS, Janssen-Cilag, Novartis, Pfizer, and Takeda outside the scope of the submitted work. CS reports personal fees from Sanofi. CT received financial supports for advisory board membership for Roche, Takeda, Janssen-Cilag, Bayer, and Celgene outside the scope of the submitted work. IS received personal fees from Sanofi. AD-I received personal fees from the EBMT foundation for data transfer during the conduct of the study. EJ received speaker’s fee and research grant from Sanofi. QL and MC are employees of Sanofi. SM received grants for travel from Gilead, and speaker fees from Roche and is an advisory board member for Bayer, outside the scope of submitted work. PD has received speaker’s honoraria from Gilead, Kite; Consultancy: AbbVie, Gilead, Janssen, and Roche. SvdW, PB, AB, DP, BEW, NR, AJ, CT, and AE declare that they have no conflict of interest.